This Department of Defense (DoD) grant, the Therapeutic Idea Award, is established to foster early-stage, innovative research focused on developing novel therapeutics for Amyotrophic Lateral Sclerosis (ALS). It aims to support projects generating highly impactful data and opening new avenues of investigation for ALS treatment. The grant specifically encourages conceptually innovative and high-risk/high-reward research with the potential to lead to critical discoveries or significant advancements in ALS therapeutics. Applicants must propose well-formulated, testable hypotheses grounded in strong scientific rationale to qualify for this award. This grant is designed to accelerate groundbreaking solutions for ALS patients.
Opportunity ID: 150933
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-12-ALSRP-TIA |
Funding Opportunity Title: | DoD Amyotrophic Lateral Sclerosis Therapeutic Idea Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 08, 2012 |
Last Updated Date: | Mar 08, 2012 |
Original Closing Date for Applications: | Jul 24, 2012 |
Current Closing Date for Applications: | Jul 24, 2012 |
Archive Date: | Aug 23, 2012 |
Estimated Total Program Funding: | $640,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The Therapeutic Idea Award is designed to promote new ideas that are still in the early stages of development with the potential to yield highly impactful data and new avenues of investigation for novel therapeutics for ALS treatment. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in ALS therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507; help@cdmrp.org
Email:help@cdmrp.org |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Updated title | Mar 08, 2012 | |
Mar 08, 2012 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-12-ALSRP-TIA |
Funding Opportunity Title: | DoD Amyotrophic Lateral Sclerosis Therapeutic Idea Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 08, 2012 |
Last Updated Date: | Mar 08, 2012 |
Original Closing Date for Applications: | Jul 24, 2012 |
Current Closing Date for Applications: | Jul 24, 2012 |
Archive Date: | Aug 23, 2012 |
Estimated Total Program Funding: | $640,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The Therapeutic Idea Award is designed to promote new ideas that are still in the early stages of development with the potential to yield highly impactful data and new avenues of investigation for novel therapeutics for ALS treatment. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in ALS therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507; help@cdmrp.org
Email:help@cdmrp.org |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-12-ALSRP-TIA |
Funding Opportunity Title: | DoD Amyotrophic Lateral SclerosisTherapeutic Idea Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 08, 2012 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Jul 24, 2012 |
Archive Date: | Aug 23, 2012 |
Estimated Total Program Funding: | $640,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The Therapeutic Idea Award is designed to promote new ideas that are still in the early stages of development with the potential to yield highly impactful data and new avenues of investigation for novel therapeutics for ALS treatment. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in ALS therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507; help@cdmrp.org
Email:help@cdmrp.org |
Related Documents
Folder 150933 Full Announcement-1 -> fy12 alsrp tia pa_gg.pdf
Packages
Agency Contact Information: | 301-682-5507; help@cdmrp.org Email: help@cdmrp.org |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00103651 | Mar 08, 2012 | Jul 24, 2012 | View |
Package 1
Mandatory forms
150933 RR_SF424_1_2-1.2.pdf
150933 PerformanceSite_1_4-1.4.pdf
150933 RR_Budget-1.1.pdf
150933 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
150933 RR_SubawardBudget30-1.2.pdf